TotalMarketCap

Nkarta

NKTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$114.242 M

$1.60 -7.80%

Close of 6 Nov 2026

As of 6 Nov 2026, Nkarta (NKTX) has a market capitalization of $114.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$104.1M

Loss-making

Shares outstanding

71,704,404

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #279Journey MedicalDERM$121.2M
  2. #280BGM GroupBGM$118.9M
  3. #281NkartaNKTX$114.2M
  4. #282Foghorn TherapeuticsFHTX$113.1M
  5. #283Minerva NeurosciencesNERV$109.8M

What if Nkarta were worth as much as…

Open the what-if tool →

Gold $28.2T

$394,233.24

Per share 247,168× higher

Bitcoin $1.53T

$21,331.27

Per share 13,374× higher

Apple $5.02T

$70,028.58

Per share 43,905× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Nkarta are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.